The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

University of Tasmania professor Andrew Files says devils have a mutated gene that might make the carnivorous marsupial more ...

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...

Few areas of the body face more daily stress and potential damage than the stomach, which must manage everything we swallow.

Researchers at Tel Aviv University's Gray Faculty of Medical and Health Sciences have uncovered how a natural and essential ...

Key Takeaways. Caregiver fear and availability meaningfully influence patient willingness to pursue CAR T and other immune effector therapies, contributing to persistently low uti ...

The research focused on macrophages, immune cells responsible for removing damaged and dead cells from the body.

A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of next-generation cell and gene therapies known as CAR immune cell therapies, ...

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...

From joint replacement and Deep TMS for depression to targeted therapy for cancer, experts highlight top U.S. medical ...